Edoardo Cignoli : Novartis Earnings Miss Forecasts

Swiss drug maker Novartis' fourth-quarter income rose 2% but sales of its newest products failed to offset a slowdown in an older drug.



via WSJ.com: US Business http://ift.tt/1e6qfxX